A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808

Stopped early · Early Phase 1

Conditions studied: Alzheimers Disease

In brief

\[F-18\]T808 is being developed as a diagnostic radiopharmaceutical for PET imaging of the human brain.

Key facts

Study ID

NCT01723488

Run by

Avid Radiopharmaceuticals

People needed

12

Starts

2012-07-01

Expected to finish

2013-03-01

Last updated by the study team

2013-07-19

Who can join

Age: 55 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

• Research Site — Irvine, California, United States
• Research Site — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.